Clinical Trial

Xenon-129 and Inert Fluorinated Gas Lung MRI: Study of Healthy Volunteers and Participants With Pulmonary Disease

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
Aim of this study is to evaluate image quality and reproducibility of Xenon-129 and Inert fluorinated (19F) gas Magnetic Resonance Imaging (MRI) and to evaluate changes in lung structure and function in participants with cystic fibrosis (CF) and asthma compared to healthy controls.
Protocol Amendment History 9 amendments
This ClinicalTrials.gov record has been amended 9 times since 2016-04-12; most recent amendment 2026-02-26.
Trial Details
NCT Number NCT02740868
Lead Sponsor The Hospital for Sick Children
Conditions Cystic Fibrosis, Asthma
Enrollment 30 participants
Start Date 2015-08
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-03-02